EPS & Dividend: Alnylam Pharmaceuticals, Inc.

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Dividend per Share 2 - - - - - - - -
Rate of return - - - - - - - -
EPS 2 -8.11 -7.46 -7.2 -9.3 -3.52 -2.009 -1.265 2.704
Distribution rate - - - - - - - -
Reference price 2 115.17 129.97 169.58 237.65 191.41 278.25 278.25 278.25
Nbr of stocks (in thousands) 111,490 116,181 119,601 123,028 125,493 128,981 128,981 -
Announcement Date 06/02/20 11/02/21 10/02/22 23/02/23 15/02/24 - - -
1USD in Million2USD
Estimates

Upcoming events: Alnylam Pharmaceuticals, Inc.

13/02/2025 13:00 Q4 2024 Earnings Release
13/02/2025 13:30 Q4 2024 Earnings Call
30/04/2025 Q1 2025 Earnings Release (Projected)
30/07/2025 Q2 2025 Earnings Release (Projected)
22/10/2025 Q3 2025 Earnings Release (Projected)
11/02/2026 Q4 2025 Earnings Release (Projected)
More events

Add to a list
Yield (Y) Yield (Y+1) P/E ratio (Y) Price to Book (Y) EV / Sales (Y)
-.--%-.--%-137.51x642.01x15.15x
0.62%0.71%68.04x45.21x17.31x
2.25%2.7%22.75x13.32x8.13x
3.08%3.26%22.34x5.22x4.32x
3.25%3.41%43.53x46.84x7.09x
3.4%3.48%15.19x5.91x3.78x
3.4%3.57%12.8x4.83x3.9x
3.5%3.67%16.85x4.94x4.28x
2.23%2.36%26.12x5.23x4.47x
2.93%3.12%33.71x25.45x6.47x
Average percentage-no-prefix percentage-no-prefix 12.38x 79.90x 7.49x
Weighted average by Cap. percentage-no-prefix percentage-no-prefix 34.01x 30.16x 8.70x
See all sector dividends

Dividend / Share (DPS) - Evolution of Analysts' Estimates

Dividend / Share (DPS) - Estimates Revisions

Earnings Per Share (EPS) - Evolution of Analysts' Estimates

Annual Profit -